Literature DB >> 24839172

Real-time quantitative PCR assay for rapid detection of murine virus contamination in bioproducts.

Luling Guo1, Zhe Zhang, Rui Gong, Gengfu Xiao.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24839172      PMCID： PMC8206288          DOI： 10.1007/s12250-014-3449-3

Source DB:  PubMed          Journal:  Virol Sin        ISSN： 1995-820X            Impact factor:   4.327


× No keyword cloud information.
  8 in total

Review 1.  Real-time PCR in virology.

Authors:  Ian M Mackay; Katherine E Arden; Andreas Nitsche
Journal:  Nucleic Acids Res       Date:  2002-03-15       Impact factor: 16.971

2.  Detection and control of mouse parvovirus.

Authors:  James D Macy; Gail A Cameron; Peter C Smith; Tracy A Ferguson; Susan R Compton
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-07       Impact factor: 1.232

3.  Identity crisis.

Authors: 
Journal:  Nature       Date:  2009-02-19       Impact factor: 49.962

4.  A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.

Authors:  Rongcheng Li; Lirong Huang; Jia Li; Zhaojun Mo; Bin He; Yunpeng Wang; Xiaohong Wu; Maria Minutello; Françoise Guinet-Morlot; Sylvie Pichon
Journal:  Vaccine       Date:  2013-10-19       Impact factor: 3.641

Review 5.  Rodent parvovirus infections.

Authors:  R O Jacoby; L J Ball-Goodrich; D G Besselsen; M D McKisic; L K Riley; A L Smith
Journal:  Lab Anim Sci       Date:  1996-08

6.  Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus.

Authors:  Joseph G Victoria; Chunlin Wang; Morris S Jones; Crystal Jaing; Kevin McLoughlin; Shea Gardner; Eric L Delwart
Journal:  J Virol       Date:  2010-04-07       Impact factor: 5.103

Review 7.  The manufacturing process for B-domain deleted recombinant factor VIII.

Authors:  R K Eriksson; C Fenge; E Lindner-Olsson; C Ljungqvist; J Rosenquist; A L Smeds ; A östlin; T Charlebois; M Leonard; B D Kelley; A Ljungqvist
Journal:  Semin Hematol       Date:  2001-04       Impact factor: 3.851

8.  A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors.

Authors:  Andrew M Scott; Fook-Thean Lee; Niall Tebbutt; Rebecca Herbertson; Sanjeev S Gill; Zhanqi Liu; Effie Skrinos; Carmel Murone; Timothy H Saunder; Bridget Chappell; Anthony T Papenfuss; Aurora M T Poon; Wendie Hopkins; Fiona E Smyth; Duncan MacGregor; Lawrence M Cher; Achim A Jungbluth; Gerd Ritter; Martin W Brechbiel; Roger Murphy; Antony W Burgess; Eric W Hoffman; Terrance G Johns; Lloyd J Old
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-28       Impact factor: 11.205
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.